Davut Pehlivan, M.D.
NPI 1558707711 · Neurology with Special Qualifications in Child Neurology Physician · Houston, TX
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Davut Pehlivan, M.D. is a Neurology with Special Qualifications in Child Neurology Physician provider in Houston, TX (NPI 1558707711).
Provider details
- NPI number
- 1558707711
- Entity type
- Individual
- Primary specialty
- Neurology with Special Qualifications in Child Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- R5794 (TX)
Specialties & taxonomies
- Neurology with Special Qualifications in Child Neurology PhysicianPrimary2084N0402XLicense R5794 (TX)
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
13 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Trofinetidebrand: Daybue | 37 |
| Clobazam | 32 |
| Levetiracetam | 20 |
| Lamotrigine | 19 |
| Trazodone Hcl | 15 |
| Levetiracetambrand: Keppra | 12 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$635 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-05-15
- Last updated
- 2023-07-21
- Certified
- 2023-07-21
Frequently asked questions
- What is Davut Pehlivan's NPI number?
- Davut Pehlivan's National Provider Identifier (NPI) is 1558707711, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Davut Pehlivan's specialty?
- Davut Pehlivan is listed in the NPPES registry with a primary specialty of Neurology with Special Qualifications in Child Neurology Physician (Allopathic & Osteopathic Physicians).
- Where is Davut Pehlivan located?
- Davut Pehlivan's practice location on file with NPPES is 6701 Fannin St Ste 1250, Houston, TX 77030.
- What is Davut Pehlivan's phone number?
- The practice phone number listed in the NPPES registry for Davut Pehlivan is (832) 822-1779.
- Does Davut Pehlivan accept Medicare?
- Davut Pehlivan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Davut Pehlivan's NPI active?
- Yes — Davut Pehlivan's NPI (1558707711) is active in the NPPES registry as of the last update on 2023-07-21.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.